In this review article, we summarize the benefits and challenges associated with lifestyle, bariatric surgery, and historical pharmacologic interventions in the treatment of obesity, before focusing ...

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, according to estimates.

UP woman dies after weight loss surgery: A bariatric surgeon explains who qualifies, who doesn’t This procedure is done on a case-specific basis and has to be medically guided at each stage ...